In the present study, we performed genotype-phenotype assessment and found that PCOS susceptibility variants in THADA and INSR, identified in previous GWAS, confers risks for MS in women with PCOS, and that variants in DENND1A and TOX3 were associated with IR. This evidence concerns the gene DENND1A and myeloid sarcoma.